ArticleFrontiers in microbiology2026
Synthetic rhizosphere bacterial communities induce systemic resistance to barley powdery mildew without major shifts in the native bacterial community.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Synthetic microbial communities (SynComs) could help plants withstand biotic stress and reduce the need for pesticides. However, it remains unclear whether SynComs composed of host- or non-host-associated rhizosphere bacteria can trigger induced systemic resistance (ISR) in barley without causing major shifts in the native rhizosphere bacterial community. Methods: Here, we constructed two SynComs with known strain composition, composed of bacterial strains isolated from the host-associated barley rhizosphere and non-host-associated wheat rhizosphere. Their ability to trigger induced systemic resistance (ISR) against the barley powdery mildew pathogen Blumeria graminis f. sp. hordei (Bgh) was tested. To investigate plant-microbe interactions from both plant and microbial perspectives, we quantified Bgh propagation in leaves by DAF staining, analysed leaf transcriptomes, and profiled the rhizosphere microbiome using 16S rRNA gene amplicon sequencing and metatranscriptomics. Results: Both SynComs reduced fungal growth in barley leaves to a similar extent as the positive control strain, Pseudomonas simiae WCS417r, suggesting that ISR-like protection can also be achieved by defined multi-strain communities. Although both SynComs provided similar overall protection, the barley SynCom exhibited the strongest numerical reduction in fungal growth. These findings build on previous single-strain ISR studies and suggest that community-mediated protection is not restricted to host-derived bacterial consortia. Inoculations with both SynComs and WCS417r were not associated with statistically significant changes in the rhizosphere bacterial community structure. All treatments induced only subtle pre-infection transcriptional responses in barley leaves that were consistent with ISR-mediated priming. However, treatment with WCS417r yielded a higher number of differentially expressed genes than either SynCom. Rhizosphere metatranscriptomics revealed treatment-specific functional shifts. The two features K05516 and PF02868 were affected by all three treatments, implying the existence of shared changes related to stress adaptation and microbial activity. OTUs matching the inoculated SynCom members were still present in the rhizosphere at harvest, suggesting the persistence of at least some of the introduced communities. Conclusion: Together, these findings suggest that SynCom-based ISR is potentially a more ecologically relevant approach to microbiome-mediated disease protection in barley.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.